Diapact crrt

Manufactured by B. Braun

Sourced in Germany

The Diapact CRRT is a continuous renal replacement therapy (CRRT) device designed for the treatment of acute kidney injury. It provides automated control and monitoring of blood and dialysate/replacement fluid flow rates, temperature, and pressure during CRRT procedures.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using diapact crrt

Vascular Access for CRRT and HP

Check if the same lab product or an alternative is used in the 5 most similar protocols

Using the Seldinger technique, an acute dual lumen catheter was inserted percutaneously either through the femoral vein or the right internal jugular for vascular access. Hemofiltration was carried out using a B. Braun Diapact CRRT machine and used a polyacrylonitrile hemofilter (B. Braun Diacap Acute L, Melsungen Germany). Blood flow rate was 200 to 250 mL/min. Replacement solution was added in pre-dilutionmode. Anticoagulation was obtained with low molecular weight heparin, and activated partial thromboplastin time was adjusted to 60 to 70 s. In combined group, concurrent PHVHF and HP were performed for the first 2 h. The HP cartridge preceded the hemofilter in the circuit. Hemoperfusion was undertaken with a resin cartridge (HA-330, Zhuhai Lizhu Group of Biological Material Co, Ltd. China) once a day. PHVHF was carried out with a daily schedule of HVHF(85 mL/kg/h)for 6 h followed by CVVH (35 mL/kg/h) for 18 h.⁵ In another group, CVVH (35 mL/kg/h) was performed for 24 h.

Chu L., Li G., Yu Y., Bao X., Wei H, & Hu M. (2020). Clinical effects of hemoperfusion combined with pulse high-volume hemofiltration on septic shock. Medicine, 99(9), e19058.

+ Open protocol

+ Expand

Continuous Veno-Venous Hemodiafiltration Procedure

Check if the same lab product or an alternative is used in the 5 most similar protocols

Continuous veno-venous hemodiafiltration was performed using Diapact CRRT B. Braun Co. (Melsungen, Germany). Synthetic high-volume membrane filters with a surface area of 1.5-2.2 m 2 were used and changed every 24 h or when filter blocking occurred. Vascular access was obtained by a double-or triple-lumen catheter using the femoral or jugular vein. Anticoagulation was provided with non-fractioned heparin, adjusting the dosage according to the value of activated partial thromboplastin time in the plasma. The procedure was performed with a low dose of heparin or without it when possible. The substitution fluid infusion rate was 1,250-1,750 mL/h in a pre-diluted or post-diluted manner, comprising 30-42 L of the total substitute in 24 h. The blood flow rate was 50-200 mL/min. The ultrafiltration rate was adjusted according to the diuresis and fluid balance.

Xu J., Cui Y, & Tian X. (2017). Early Continuous Veno-Venous Hemofiltration Is Effective in Decreasing Intra-Abdominal Pressure and Serum Interleukin-8 Level in Severe Acute Pancreatitis Patients with Abdominal Compartment Syndrome. Blood purification, 44(4).

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!